Patent · US Active

Pharmaceutical formulation for histone deacetylase inhibitors

US11607399B2 · kind B2 · utility

0Cited by

8References

19Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Todd W. Chappell · Boston, US
Keith Johnson · Durham, US

Key dates

Filing date	Jul 9, 2020
Grant date	Mar 21, 2023
Priority date	—
Expiry date	Oct 19, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C259/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition, comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) compound represented by the following structural formula

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.